Publications
Showing records 1 - 20 (of 36)
Publication: JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID
Author
Year
Title
Publisher
1193332 Gross,M; Obermann,E; Weinand,K; Zimmermann,F; Rochlitz,C
2008
Der aktuelle Stand beim invasiven, nicht hämatogen metastasierten Mammakarzinom
InfoOnkologie
1195880 Salzberg, M.; Kirson, E.; Palti, Y.; Rochlitz, C.
2008
A pilot study with very low-intensity, intermediate-frequency electric fields in patients with locally advanced and/or metastatic solid tumors
Onkologie
1196976 Dummer, Reinhard; Rochlitz, Christoph; Velu, Thierry; Acres, Bruce; Limacher, Jean-Marc; Bleuzen, Pascal; Lacoste, Gisèle; Slos, Philippe; Romero, Pedro; Urosevic, Mirjana
2008
Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanoma
Molecular therapy
1195458 Iten, Fabienne; Muller, Beat; Schindler, Christian; Rasch, Helmut; Rochlitz, Christoph; Oertli, Daniel; Maecke, Helmut R.; Muller-Brand, Jan; Walter, Martin A.
2009
[(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial
Cancer
1193484 Rochlitz, Christoph
2009
Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer
Neoplasia
1195473 Güth, Uwe; Huang, Dorothy Jane; Dirnhofer, Stephan; Rochlitz, Christoph; Wight, Edward
2009
Distant metastatic breast cancer as an incurable disease : a tenet with a need for revision
The cancer journal : the official journal of the American Radium Society
2832805 Rajski, Michal; Zanetti-Dällenbach, Rosanna; Vogel, Brigitte; Herrmann, Richard; Rochlitz, Christoph; Buess, Martin
2010
IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients
BMC medicine
1194501 Vetter, Marcus; Tzankov, Alexandar; Engert, Andreas; Mehling, Matthias; Herrmann, Richard; Rochlitz, Christoph
2011
Hodgkin's Lymphoma and Paraneoplastic Phenomena in the Central Nervous System : A Case Report and Review of the Literature
Case Reports in Oncology
1192817 Zaman, K.
2011
Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer : a multicenter, single-arm phase II trial (SAKK 24/06)
Annals of oncology
1023048 Imhof, Anna; Brunner, Philippe; Marincek, Nicolas; Briel, Matthias; Schindler, Christian; Rasch, Helmut; Mäcke, Helmut R; Rochlitz, Christoph; Müller-Brand, Jan; Walter, Martin A
2011
Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
1193767 Huober, Jens; Baumann, Michael; Rochlitz, Christoph; Aebi, Stefan; Güth, Uwe; von Moos, Roger; Müller, Andreas; von Rohr, Lukas; Widmer, Isabelle; Thürlimann, Beat
2011
Trastuzumab treatment beyond progression in advanced breast cancer : patterns of care in six Swiss breast cancer centers
Oncology
1192856 Schmid, S M; Myrick, M E; Forrer, F; Obermann, E C; Viehl, C T; Rochlitz, C; Güth, U
2011
Sentinel lymph node biopsy in primary breast cancer : trust the radiolabeled colloid method and avoid unnecessary procedures
European journal of surgical oncology
2832804 Rajski, M.; Vogel, B.; Baty, F.; Rochlitz, C.; Buess, M.
2012
Global gene expression analysis of the interaction between cancer cells and osteoblasts to predict bone metastasis in breast cancer
PLoS ONE
2832802 Mamot, Christoph; Ritschard, Reto; Wicki, Andreas; Stehle, Gregor; Dieterle, Thomas; Bubendorf, Lukas; Hilker, Christoph; Deuster, Stefanie; Herrmann, Richard; Rochlitz, Christoph
2012
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
The Lancet oncology
2832801 Mamot, Christoph; Ritschard, Reto; Wicki, Andreas; Küng, Willy; Schuller, Jan; Herrmann, Richard; Rochlitz, Christoph
2012
Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells
Journal of drug targeting
1193117 Wicki, Andreas; Rochlitz, Christoph; Orleth, Annette; Ritschard, Reto; Albrecht, Imke; Herrmann, Richard; Christofori, Gerhard; Mamot, Christoph
2012
Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth
Clinical cancer research
2832808 Wicki, Andreas; Rochlitz, Christoph
2012
Targeted therapies in breast cancer
Swiss medical weekly
1635005 Marincek, Nicolas; Jörg, Ann-Catherine; Brunner, Philippe; Schindler, Christian; Koller, Michael T; Rochlitz, Christoph; Müller-Brand, Jan; Maecke, Helmut R; Briel, Matthias; Walter, Martin A
2013
Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors : long-term outcome of a phase I dose escalation study
Journal of translational medicine
2832800 Bontognali, S.; Pless, M.; Brutsche, M. H.; Fischer, C.; Rochlitz, C.; Buess, M.
2013
Analysis of the EGFR mutation status in head and neck squamous cell carcinoma before treatment with Gefitinib
Onkologie
4407714 Wicki, Andreas; Hermann, Frank; Prêtre, Vincent; Winterhalder, Ralph; Kueng, Marc; von Moos, Roger; Rochlitz, Christoph; Herrmann, Richard
2014
Pre-existing antihypertensive treatment predicts early increase in blood pressure during bevacizumab therapy: the prospective AVALUE cohort study
Oncol Res Treat
Showing records 1 - 20 (of 36)
